ロード中...
Comment on: ApoE-directed therapeutics rapidly clear β-amyloid and reverse deficits in AD mouse models
Cramer et al. (Reports, 23 March 2012: 1503-1506) (1) demonstrated that treatment of APP/PS1ΔE9 mice with bexarotene decreased Aβ pathology and ameliorated memory deficits. We confirm the reversal of memory deficits in APP/PS1ΔE9 mice expressing human APOE3 or APOE4 to the levels of their non-transg...
保存先:
| 主要な著者: | , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2013
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4086452/ https://ncbi.nlm.nih.gov/pubmed/23704552 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1126/science.1235809 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|